Plasma Kidney Injury Molecule-1 Dynamics During First-Line Immunotherapy with or without Cabozantinib in Advanced Renal Cell Carcinoma. Presented by @VincentWenxinXu @DanaFarber. #ESMO26 written coverage by @rksayyid @UAUrology > https://bit.ly/4klZZGi #KidneyCancer #RCC #Immunotherapy @myESMO